Abstract
Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have